Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Calmer Co International is an Australian-based health and wellness company specializing in the development and commercialization of natural products derived from kava. Formerly known as Fiji Kava, the company focuses on providing natural alternatives for managing anxiety, stress, and sleep disorders through its proprietary kava extract formulations. Their product portfolio includes capsules, powders, and ready-to-drink beverages marketed under brands like Fiji Kava, Taki Mai, and Danodan. The company maintains a vertically integrated supply chain, sourcing high-quality kava from Fiji to ensure purity and potency. By leveraging traditional medicinal knowledge with modern scientific standards, The Calmer Co aims to become a global leader in the kava-based nutraceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Calmer Co International.